News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Canyon Pharmaceuticals Announces Study Published in the Journal of Thrombosis and Haemostasis



6/20/2012 11:50:38 AM

PARSIPPANY, N.J.--(BUSINESS WIRE)--Orthopedic surgery patients with Stage 3B chronic kidney disease (CKD) are at high risk for blood clots despite standard treatment with the anticoagulant enoxaparin, according to a recently published study. Blood clots and post-operative bleeding were reduced with use of desirudin, a new type of anticoagulant.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES